Pfizer Stock Has Risen Due to COVID-19 Vaccine Efforts

“Pfizer $PFE stock rose 1.7% in extended trading on Thursday. The company announced that it identified a lead drug to treat COVID-19.”

#pfizer #vaccine #drug #covid19
https://t.co/CfKXlIyP4g https://t.co/W8Ond7rVxo